title: I petitioned the FDA to restrict hypnotics: here is why.
authors.affiliation: 8437 Sugarman Drive, La Jolla, CA 92037-2226, USA. Electronic address: dkripke1@san.rr.com.
authors.forename: Daniel F
authors.initials: DF
authors.lastname: Kripke
mesh_terms: D017327:Clinical Trials, Phase IV as Topic; D004335:Drug and Narcotic Control / Q000379:methods; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000009:adverse effects*; D009026:Mortality; D016032:Randomized Controlled Trials as Topic; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D006993:Hypnotics and Sedatives